Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 27 June 2025

Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1649116

Correction: Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer

This article is a correction to:

  1. Identification and validation of monocyte to macrophage differentiation associated (MMD) as a prognostic biomarker in gastric cancer

    1. Read original article
Suyang Bai,,&#x;Suyang Bai1,2,3†Zhaofeng Chen,&#x;Zhaofeng Chen2,3†Rui Ji,&#x;Rui Ji2,3†Yuping Wang,&#x;Yuping Wang2,3†Yongning Zhou,*Yongning Zhou2,3*Qinghong Guo,*Qinghong Guo2,3*Liang Qiao,,,*Liang Qiao1,2,3,4*
  • 1The First Clinical Medical College, Lanzhou University, Lanzhou, China
  • 2Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China
  • 3Gansu Province Clinical Research Center for Digestive Diseases, The First Hospital of Lanzhou University, Lanzhou, China
  • 4Storr Liver Centre, The Westmead Institute for Medical Research (WIMR), The University of Sydney, Westmead, NSW, Australia

A Correction on
Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer

By Bai S, Chen Z, Ji R, Wang Y, Zhou Y, Guo Q and Qiao L (2025) Front. Oncol. 15:1508355. doi: 10.3389/fonc.2025.1508355

Affiliations 1, 2 and 3 were omitted for author Liang Qiao. These affiliations have now been added for author Liang Qiao.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: MMD, stomach neoplasms, prognosis, biomarker, miR-200b-3p

Citation: Bai S, Chen Z, Ji R, Wang Y, Zhou Y, Guo Q and Qiao L (2025) Correction: Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer. Front. Oncol. 15:1649116. doi: 10.3389/fonc.2025.1649116

Received: 18 June 2025; Accepted: 19 June 2025;
Published: 27 June 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Bai, Chen, Ji, Wang, Zhou, Guo and Qiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Liang Qiao, bGlhbmcucWlhb0BzeWRuZXkuZWR1LmF1; Qinghong Guo, Z3FoQGx6dS5lZHUuY24=; Yongning Zhou, emhvdXluQGx6dS5lZHUuY24=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.